Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Presymptomatic Noninvasive Assessment of Fetal Well-being by Genome-wide RNA Sequencing.

Oudejans CBM.

Clin Chem. 2018 Oct 16. pii: clinchem.2018.294199. doi: 10.1373/clinchem.2018.294199. [Epub ahead of print] No abstract available.

PMID:
30327300
2.

The effect of maternal NODAL on STOX1 expression in extravillous trophoblasts is mediated by IGF1.

Visser A, Beijer M, Oudejans CBM, van Dijk M.

PLoS One. 2018 Aug 9;13(8):e0202190. doi: 10.1371/journal.pone.0202190. eCollection 2018.

3.

Response to letter to the editor PD-17-0390, a comment on "Comparing methods for fetal fraction determination and quality control of NIPT samples".

van Beek DM, Straver R, Weiss MM, Boon EMJ, Huijsdens-van Amsterdam K, Oudejans CBM, Reinders MJT, Sistermans EA.

Prenat Diagn. 2017 Dec;37(12):1266-1267. doi: 10.1002/pd.5170. No abstract available.

4.

Comparing methods for fetal fraction determination and quality control of NIPT samples.

van Beek DM, Straver R, Weiss MM, Boon EMJ, Huijsdens-van Amsterdam K, Oudejans CBM, Reinders MJT, Sistermans EA.

Prenat Diagn. 2017 Aug;37(8):769-773. doi: 10.1002/pd.5079. Epub 2017 Jul 10.

5.

Identification of HIF-2α-regulated genes that play a role in human microvascular endothelial sprouting during prolonged hypoxia in vitro.

Nauta TD, van den Broek M, Gibbs S, van der Pouw-Kraan TC, Oudejans CB, van Hinsbergh VW, Koolwijk P.

Angiogenesis. 2017 Feb;20(1):39-54. doi: 10.1007/s10456-016-9527-4. Epub 2016 Oct 3.

6.

Noncoding RNA-regulated gain-of-function of STOX2 in Finnish pre-eclamptic families.

Oudejans CB, Poutsma A, Michel OJ, Thulluru HK, Mulders J, van de Vrugt HJ, Sistermans EA, van Dijk M.

Sci Rep. 2016 Aug 24;6:32129. doi: 10.1038/srep32129.

7.

Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.

Tamminga S, van Maarle M, Henneman L, Oudejans CB, Cornel MC, Sistermans EA.

Adv Clin Chem. 2016;74:63-102. doi: 10.1016/bs.acc.2015.12.004. Epub 2016 Jan 21. Review.

PMID:
27117661
8.

MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type III.

Janssen R, Zuidwijk MJ, Muller A, van Mil A, Dirkx E, Oudejans CB, Paulus WJ, Simonides WS.

Front Endocrinol (Lausanne). 2016 Mar 9;7:22. doi: 10.3389/fendo.2016.00022. eCollection 2016.

9.

Calculating the fetal fraction for noninvasive prenatal testing based on genome-wide nucleosome profiles.

Straver R, Oudejans CB, Sistermans EA, Reinders MJ.

Prenat Diagn. 2016 Jul;36(7):614-21. doi: 10.1002/pd.4816. Epub 2016 May 20.

10.

Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease.

van Harten AC, Mulders J, Scheltens P, van der Flier WM, Oudejans CB.

J Alzheimers Dis. 2015;47(1):243-52. doi: 10.3233/JAD-140075.

PMID:
26402772
11.

Circulating Nucleic Acids Special Issue.

Chiu RW, Oudejans CB.

Clin Biochem. 2015 Oct;48(15):931. doi: 10.1016/j.clinbiochem.2015.08.021. Epub 2015 Aug 24. No abstract available.

PMID:
26315671
12.

Mutations within the LINC-HELLP non-coding RNA differentially bind ribosomal and RNA splicing complexes and negatively affect trophoblast differentiation.

van Dijk M, Visser A, Buabeng KM, Poutsma A, van der Schors RC, Oudejans CB.

Hum Mol Genet. 2015 Oct 1;24(19):5475-85. doi: 10.1093/hmg/ddv274. Epub 2015 Jul 14.

PMID:
26173455
13.

Maternal plasma RNA sequencing.

Oudejans CB.

Clin Biochem. 2015 Oct;48(15):942-7. doi: 10.1016/j.clinbiochem.2015.03.004. Epub 2015 Mar 16. Review.

PMID:
25792020
14.

ACVR2A promoter polymorphism rs1424954 in the Activin-A signaling pathway in trophoblasts.

Thulluru HK, Michel OJ, Oudejans CB, van Dijk M.

Placenta. 2015 Apr;36(4):345-9. doi: 10.1016/j.placenta.2015.01.010. Epub 2015 Jan 26.

15.

Susceptibility allele-specific loss of miR-1324-mediated silencing of the INO80B chromatin-assembly complex gene in pre-eclampsia.

Oudejans CB, Michel OJ, Janssen R, Habets R, Poutsma A, Sistermans EA, Weiss MM, Incarnato D, Oliviero S, Kleiverda G, Van Dijk M, Arngrímsson R.

Hum Mol Genet. 2015 Jan 1;24(1):118-27. doi: 10.1093/hmg/ddu423. Epub 2014 Aug 20.

16.

Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.

Yu SC, Chan KC, Zheng YW, Jiang P, Liao GJ, Sun H, Akolekar R, Leung TY, Go AT, van Vugt JM, Minekawa R, Oudejans CB, Nicolaides KH, Chiu RW, Lo YM.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8583-8. doi: 10.1073/pnas.1406103111. Epub 2014 May 19.

17.

WISECONDOR: detection of fetal aberrations from shallow sequencing maternal plasma based on a within-sample comparison scheme.

Straver R, Sistermans EA, Holstege H, Visser A, Oudejans CB, Reinders MJ.

Nucleic Acids Res. 2014 Mar;42(5):e31. doi: 10.1093/nar/gkt992. Epub 2013 Oct 28.

18.

MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.

Kuster DW, Mulders J, Ten Cate FJ, Michels M, Dos Remedios CG, da Costa Martins PA, van der Velden J, Oudejans CB.

J Mol Cell Cardiol. 2013 Dec;65:59-66. doi: 10.1016/j.yjmcc.2013.09.012. Epub 2013 Sep 29.

PMID:
24083979
19.

Maternal plasma bisulfite DNA sequencing: tomorrow starts today.

Oudejans CB.

Clin Chem. 2013 Nov;59(11):1547-9. doi: 10.1373/clinchem.2013.212787. Epub 2013 Aug 23. No abstract available.

20.

Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region.

Janssen R, Zuidwijk M, Muller A, Mulders J, Oudejans CB, Simonides WS.

Endocrinology. 2013 Jun;154(6):1973-8. doi: 10.1210/en.2012-2017. Epub 2013 Apr 3.

PMID:
23554452
21.

HELLP babies link a novel lincRNA to the trophoblast cell cycle.

van Dijk M, Thulluru HK, Mulders J, Michel OJ, Poutsma A, Windhorst S, Kleiverda G, Sie D, Lachmeijer AM, Oudejans CB.

J Clin Invest. 2012 Nov;122(11):4003-11. doi: 10.1172/JCI65171. Epub 2012 Oct 24.

22.

STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease.

van Abel D, Abdulhamid O, Scheper W, van Dijk M, Oudejans CB.

Neurosci Lett. 2012 Oct 24;528(2):104-9. doi: 10.1016/j.neulet.2012.09.017. Epub 2012 Sep 17.

PMID:
22995177
23.

Direct downregulation of CNTNAP2 by STOX1A is associated with Alzheimer's disease.

van Abel D, Michel O, Veerhuis R, Jacobs M, van Dijk M, Oudejans CB.

J Alzheimers Dis. 2012;31(4):793-800. doi: 10.3233/JAD-2012-120472.

PMID:
22728895
24.

Noninvasive prenatal diagnostics by maternal plasma DNA sequencing.

Oudejans CB.

Expert Rev Mol Diagn. 2012 Jun;12(5):445-7. doi: 10.1586/erm.12.35.

PMID:
22702361
25.

Naturally occurring variation in trophoblast invasion as a source of novel (epigenetic) biomarkers.

van Dijk M, Visser A, Posthuma J, Poutsma A, Oudejans CB.

Front Genet. 2012 Feb 20;3:22. doi: 10.3389/fgene.2012.00022. eCollection 2012.

26.

Transcription factor STOX1A promotes mitotic entry by binding to the CCNB1 promotor.

Abel Dv, Abdul-Hamid O, Dijk Mv, Oudejans CB.

PLoS One. 2012;7(1):e29769. doi: 10.1371/journal.pone.0029769. Epub 2012 Jan 13.

27.

Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples.

Kester MI, van der Flier WM, Visser A, Blankenstein MA, Scheltens P, Oudejans CB.

Clin Chem Lab Med. 2011 Sep 23;50(1):61-5. doi: 10.1515/CCLM.2011.731.

PMID:
21942811
28.

SFRS7-mediated splicing of tau exon 10 is directly regulated by STOX1A in glial cells.

van Abel D, Hölzel DR, Jain S, Lun FM, Zheng YW, Chen EZ, Sun H, Chiu RW, Lo YM, van Dijk M, Oudejans CB.

PLoS One. 2011;6(7):e21994. doi: 10.1371/journal.pone.0021994. Epub 2011 Jul 6.

29.

Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing.

Chen EZ, Chiu RW, Sun H, Akolekar R, Chan KC, Leung TY, Jiang P, Zheng YW, Lun FM, Chan LY, Jin Y, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM.

PLoS One. 2011;6(7):e21791. doi: 10.1371/journal.pone.0021791. Epub 2011 Jul 6.

30.

Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.

Sombekke MH, van der Voort LF, Kragt JJ, Nielsen JM, Guzel H, Visser A, Oudejans CB, Crusius JB, Peña AS, Vrenken H, Polman CH, Killestein J.

Mult Scler. 2011 Aug;17(8):922-30. doi: 10.1177/1352458511402411. Epub 2011 May 4.

PMID:
21543551
31.

STOX1: Key player in trophoblast dysfunction underlying early onset preeclampsia with growth retardation.

van Dijk M, Oudejans CB.

J Pregnancy. 2011;2011:521826. doi: 10.1155/2011/521826. Epub 2010 Dec 15. Review.

32.

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, Lun FM, Go AT, Lau ET, To WW, Leung WC, Tang RY, Au-Yeung SK, Lam H, Kung YY, Zhang X, van Vugt JM, Minekawa R, Tang MH, Wang J, Oudejans CB, Lau TK, Nicolaides KH, Lo YM.

BMJ. 2011 Jan 11;342:c7401. doi: 10.1136/bmj.c7401.

33.

Non-invasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities.

Go AT, van Vugt JM, Oudejans CB.

Hum Reprod Update. 2011 May-Jun;17(3):372-82. doi: 10.1093/humupd/dmq054. Epub 2010 Nov 12. Review.

PMID:
21076134
34.

Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS.

van der Voort LF, Vennegoor A, Visser A, Knol DL, Uitdehaag BM, Barkhof F, Oudejans CB, Polman CH, Killestein J.

Neurology. 2010 Oct 5;75(14):1228-33. doi: 10.1212/WNL.0b013e3181f6c556.

PMID:
20921509
35.

Differential methylation of STOX1 in human placenta.

van Dijk M, Drewlo S, Oudejans CB.

Epigenetics. 2010 Nov-Dec;5(8):736-42. doi: 10.4161/epi.5.8.13084. Epub 2010 Nov 1.

PMID:
20716964
36.

The STOX1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by alpha-T-catenin upregulation.

van Dijk M, van Bezu J, van Abel D, Dunk C, Blankenstein MA, Oudejans CB, Lye SJ.

Hum Mol Genet. 2010 Jul 1;19(13):2658-67. doi: 10.1093/hmg/ddq152. Epub 2010 Apr 16.

PMID:
20400461
37.

The pre-eclampsia gene STOX1 controls a conserved pathway in placenta and brain upregulated in late-onset Alzheimer's disease.

van Dijk M, van Bezu J, Poutsma A, Veerhuis R, Rozemuller AJ, Scheper W, Blankenstein MA, Oudejans CB.

J Alzheimers Dis. 2010;19(2):673-9. doi: 10.3233/JAD-2010-1265.

PMID:
20110611
38.

Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis.

van der Voort LF, Visser A, Knol DL, Oudejans CB, Polman CH, Killestein J.

Eur J Neurol. 2009 Sep;16(9):1049-52. doi: 10.1111/j.1468-1331.2009.02649.x. Epub 2009 May 22.

PMID:
19486142
39.

Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice.

van der Voort LF, Kok A, Visser A, Oudejans CB, Caldano M, Gilli F, Bertolotto A, Polman CH, Killestein J.

Mult Scler. 2009 Feb;15(2):212-8. doi: 10.1177/1352458508096877. Epub 2008 Sep 19.

PMID:
18805837
40.

A novel method to identify syncytiotrophoblast-derived RNA products representative of trisomy 21 placental RNA in maternal plasma.

Go AT, Visser A, van Dijk M, Mulders MA, Eijk P, Ylstra B, Blankenstein MA, van Vugt JM, Oudejans CB.

Methods Mol Biol. 2008;444:291-302. doi: 10.1007/978-1-59745-066-9_23.

PMID:
18425490
41.

Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates.

Smets EM, Deurloo KL, Go AT, van Vugt JM, Blankenstein MA, Oudejans CB.

Prenat Diagn. 2008 Apr;28(4):299-303. doi: 10.1002/pd.1969.

PMID:
18317999
42.

Noncoding RNA and DNA as biomarkers: toward an epigenetic fetal barcode for use in maternal plasma.

Oudejans CB.

Clin Chem. 2008 Mar;54(3):456-7. doi: 10.1373/clinchem.2007.100123. No abstract available.

43.

44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21.

Go AT, Visser A, Mulders MA, Blankenstein MA, van Vugt JM, Oudejans CB.

Clin Chem. 2007 Dec;53(12):2223-4. doi: 10.1373/clinchem.2007.093146. No abstract available.

44.

Measurement of allelic-expression ratios in trisomy 21 placentas by quencher extension of heterozygous samples identified by partially denaturing HPLC.

Go AT, Visser A, Betsalel OT, van Vugt JM, Blankenstein MA, Oudejans CB.

Clin Chem. 2008 Feb;54(2):437-40. doi: 10.1373/clinchem.2007.095539.

45.

Non-coding RNA and DNA as epigenetic biomarkers for pre-eclampsia.

Oudejans CB.

Expert Opin Med Diagn. 2008 Jan;2(1):81-9. doi: 10.1517/17530059.2.1.81.

PMID:
23485118
46.

Placental gene expression and pre-eclampsia.

Oudejans CB, van Dijk M.

Placenta. 2008 Mar;29 Suppl A:S78-82. Epub 2007 Oct 23. Review.

PMID:
17959244
47.

Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors.

Westerman BA, Breuer RH, Poutsma A, Chhatta A, Noorduyn LA, Koolen MG, Postmus PE, Blankenstein MA, Oudejans CB.

Int J Biol Markers. 2007 Apr-Jun;22(2):114-23.

PMID:
17549667
48.

C21ORF105, A chromosome 21-encoded mRNA, is not a discriminative marker gene for prediction of Down syndrome in maternal plasma.

Go AT, Visser A, Mulders MA, Twisk JW, Blankenstein MA, van Vugt JM, Oudejans CB.

Prenat Diagn. 2007 Feb;27(2):146-9.

PMID:
17186567
49.

Genetics of preeclampsia: paradigm shifts.

Oudejans CB, van Dijk M, Oosterkamp M, Lachmeijer A, Blankenstein MA.

Hum Genet. 2007 Jan;120(5):607-12. Epub 2006 Sep 26. Review.

PMID:
17024365
50.

Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations.

van de Wiel MA, Costa JL, Smid K, Oudejans CB, Bergman AM, Meijer GA, Peters GJ, Ylstra B.

Cancer Res. 2005 Nov 15;65(22):10208-13.

Supplemental Content

Loading ...
Support Center